Wegovy
POINT
Naturally suppresses appetite through the GLP-1 receptor
Once-weekly injection with sustained weight loss effects for up to 68 weeks
FDA-approved and approved by the Korean Ministry of Food and Drug Safety for obesity treatment
Scientifically proven obesity treatment based on semaglutide
PLUS
Start Your Healthy Transformation, Structured Weight Management, Scientifically Proven
Wegovy
Wegovy is a once-weekly subcutaneous injection containing semaglutide, a GLP-1 receptor agonist approved for obesity treatment. It mimics the GLP-1 hormone naturally released after meals to increase satiety, suppress appetite, and slow gastric emptying, helping reduce calorie intake and support effective weight management.
Appetite Control with Wegovy
Reduce the Burden on Your Body Through a GLP-1-Like Mechanism
GLP-1 is a hormone released after meals that promotes satiety and suppresses appetite. The semaglutide in Wegovy mimics this hormone by slowing gastric emptying and sending signals to the brain that you are full. As a result, food intake naturally decreases while supporting long-term weight loss and improved metabolic health.
Wegovy dosing schedule
Once Weekly, Anytime That Fits Your Schedule
Starting dose: 0.25mg/week (for 4 weeks)
Maintenance dose: 0.5mg/week (for at least 4 weeks)
Dose escalation: 1.0mg → 1.7mg → up to 2.4mg/week
* Each Wegovy prefilled pen is for single use only.
Achieve Both Weight Loss and Blood Sugar Control
How to Use the Wegovy Pen
Choose an injection site on the abdomen, thigh, or back of the arm and clean the area with an alcohol swab.
Remove the pen cap and make sure the injection needle is securely attached.
Place the pen vertically against the injection site.
Press the injection button until you hear a "click", then continue holding it in place for 6 seconds.
When the viewing window turns yellow, the injection is complete. Confirm that the injection has been successfully administered.
· Dispose of the pen after a single use.
· Never reuse the injection pen.
· Monitor carefully for possible side effects such as abdominal pain or nausea after the injection.
Recommended for
Those who have used Saxenda but want a stronger and longer-lasting effect
Those who prefer convenient once-weekly weight management
Those with weight-related conditions such as hypertension or dyslipidemia
Those seeking a medically supervised and scientifically proven obesity treatment
Those looking for additional support beyond diet and exercise
Expected effects
Natural appetite suppression
Average 15% weight loss over 68 weeks in clinical trials
Reduced meal size naturally due to decreased hunger
Improved blood glucose control and insulin sensitivity
Increased energy efficiency and reduced fatigue
Reduced fat cells
and lower body fat percentage
Q&A
Which should I choose, Wegovy or Mounjaro?
Wegovy is a GLP-1 receptor agonist, while Mounjaro is a dual GIP/GLP-1 receptor. Wegovy is generally recommended for patients beginning obesity treatment or those who meet the approved prescribing criteria.
How many pens are in one box of Wegovy?
Wegovy is supplied as a single-use prefilled injection pen. Each carton contains 4 pens, providing a total of 4 weekly injections.
I Missed My Scheduled Wegovy Dose. What Should I Do?
If you remember within 5 days (120 hours) of the missed dose, administer it as soon as possible. If more than 5 days have passed, skip the missed dose and administer your next dose on your regularly scheduled day. Then continue your regular once-weekly dosing schedule.
How should Wegovy be stored?
Store Wegovy in its original carton to protect it from light and keep it refrigerated at 2-8 degrees Celsius (36-46 degree fahrenheit). If refrigeration is unavailable, it may be stored at temperatures below 30degrees Celsiuss (86 degree fahrenheit) for up to 28 days. Do not freeze the medication. If it has been frozen, do not use it.
Wegovy
POINT
Naturally suppresses appetite through the GLP-1 receptor
Once-weekly injection with sustained weight loss effects for up to 68 weeks
FDA-approved and approved by the Korean Ministry of Food and Drug Safety for obesity treatment
Scientifically proven obesity treatment based on semaglutide
PLUS
Start Your Healthy Transformation, Structured Weight Management, Scientifically Proven
Wegovy
Wegovy is a once-weekly subcutaneous injection containing semaglutide, a GLP-1 receptor agonist approved for obesity treatment. It mimics the GLP-1 hormone naturally released after meals to increase satiety, suppress appetite, and slow gastric emptying, helping reduce calorie intake and support effective weight management.
Appetite Control with Wegovy
Reduce the Burden on Your Body Through a GLP-1-Like Mechanism
GLP-1 is a hormone released after meals that promotes satiety and suppresses appetite. The semaglutide in Wegovy mimics this hormone by slowing gastric emptying and sending signals to the brain that you are full. As a result, food intake naturally decreases while supporting long-term weight loss and improved metabolic health.
Wegovy dosing schedule
Once Weekly, Anytime That Fits Your Schedule
Starting dose: 0.25mg/week (for 4 weeks)
Maintenance dose: 0.5mg/week (for at least 4 weeks)
Dose escalation: 1.0mg → 1.7mg → up to 2.4mg/week
* Each Wegovy prefilled pen is for single use only.
Achieve Both Weight Loss and Blood Sugar Control
How to Use the Wegovy Pen
Choose an injection site on the abdomen, thigh, or back of the arm and clean the area with an alcohol swab.
Remove the pen cap and make sure the injection needle is securely attached.
Place the pen vertically against the injection site.
Press the injection button until you hear a "click", then continue holding it in place for 6 seconds.
When the viewing window turns yellow, the injection is complete. Confirm that the injection has been successfully administered.
· Dispose of the pen after a single use.
· Never reuse the injection pen.
· Monitor carefully for possible side effects such as abdominal pain or nausea after the injection.
Recommended for
Those who have used Saxenda but want a stronger and longer-lasting effect
Those who prefer convenient once-weekly weight management
Those with weight-related conditions such as hypertension or dyslipidemia
Those seeking a medically supervised and scientifically proven obesity treatment
Those looking for additional support beyond diet and exercise
Expected effects
Natural appetite suppression
Average 15% weight loss over 68 weeks in clinical trials
Reduced meal size naturally due to decreased hunger
Improved blood glucose control and insulin sensitivity
Increased energy efficiency and reduced fatigue
Reduced fat cells
and lower body fat percentage
Q&A
Which should I choose, Wegovy or Mounjaro?
Wegovy is a GLP-1 receptor agonist, while Mounjaro is a dual GIP/GLP-1 receptor. Wegovy is generally recommended for patients beginning obesity treatment or those who meet the approved prescribing criteria.
How many pens are in one box of Wegovy?
Wegovy is supplied as a single-use prefilled injection pen. Each carton contains 4 pens, providing a total of 4 weekly injections.
I Missed My Scheduled Wegovy Dose. What Should I Do?
If you remember within 5 days (120 hours) of the missed dose, administer it as soon as possible. If more than 5 days have passed, skip the missed dose and administer your next dose on your regularly scheduled day. Then continue your regular once-weekly dosing schedule.
How should Wegovy be stored?
Store Wegovy in its original carton to protect it from light and keep it refrigerated at 2-8 degrees Celsius (36-46 degree fahrenheit). If refrigeration is unavailable, it may be stored at temperatures below 30degrees Celsiuss (86 degree fahrenheit) for up to 28 days. Do not freeze the medication. If it has been frozen, do not use it.